Skin Lightening Prevalent Among 'Skin of Color' Individuals
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 19, 2023 -- Among skin of color (SOC) individuals, use of skin lightening (SL), involving the use of chemicals to lighten the skin, is prevalent, and those using SL agents rarely consult a medical provider before using the products, according to a study published in the October issue of the International Journal of Women's Dermatology.
Karishma Daftary, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined SL habits among SOC individuals in the United States. A cross-sectional survey was administered to SOC individuals and data were collected on demographics, rates of SL, SL habits, and perceived colorism among SL users and nonusers.
Four hundred fifty-five participants completed the survey. The researchers found that 21.3 percent of participants reported using SL agents: 73.2 and 26.8 percent for treatment of a skin condition and for general SL. Before using the products, only 22.6 percent of SL users consulted a medical provider. Overall, 45.4 percent were unaware of their SL product ingredients and 35.1 percent reported use of hydroquinone-based products. Compared with nonusers, SL users had significantly higher composite colorism scores (20.03 versus 18.20 percent).
"These findings underscore the important role of dermatologists in addressing skin tone and pigmentary concerns with their SOC patients, as patients may be using SL agents for a variety of reasons: most commonly for self-treatment of a skin condition but also for general SL," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Disparities Seen in Cancer Treatment Delivery at Minority-Serving Hospitals
TUESDAY, May 28, 2024 -- There are systemic disparities in definitive cancer treatment delivery at minority-serving hospitals (MSHs) versus non-MSHs, according to a study...
One in Nine U.S. Children Have Ever Been Diagnosed With ADHD
THURSDAY, May 23, 2024 -- Diagnoses of attention-deficit/hyperactivity disorder (ADHD) in U.S. children continue to increase, with approximately one in nine having ever received a...
2024 ASCO Annual Meeting to Focus on Clinical Cancer Research Impacting Patient Care
THURSDAY, May 23, 2024 -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held May 31 to June 4, 2024, in Chicago and online. The theme of this...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.